Author

Y. K. Zhang

Observed name: Y. Zhang

OpenAlex ID: A5126479340

Abstract PS3-07-24: Breast Cancer Index re-stratifies 21-gene assay risk groups for risk of recurrence and extended endocrine therapy benefit: Final Analysis of the BCI Registry Study

2026 · V. Chuy, N. Siuliukina, et al. · Clinical Cancer Research

Abstract PS3-07-28: Prognostic performance of Breast Cancer Index in patients with early-stage HR+ HER2+ breast cancer (BC) treated with adjuvant trastuzumab: NCCTG N9831 (Alliance)

2026 · S. Chumsri, E. Liu, et al. · Clinical Cancer Research

Abstract PS3-08-07: Comparative Analysis of Breast Cancer Index Testing in Hispanic and Non-Hispanic Populations

2026 · A. C. Sandoval-Leon, N. Siuliukina, et al. · Clinical Cancer Research

Abstract PS3-07-27: Identifying Premenopausal Patients with Early-Stage Hormone Receptor-Positive Node-Negative Breast Cancer at Minimal Risk of Distant Recurrence by Breast Cancer Index

2026 · R. O'Regan, Y. Ren, et al. · Clinical Cancer Research

Abstract PS2-08-25: Endocrine Sensitivity and Predicted Benefit of Extended Endocrine Therapy based on Breast Cancer Index (BCI) in BRCA1, BRCA2 and CHEK2 Pathogenic Variant Carriers with ER+/HER2- Breast Cancer

2026 · S. Yadav, B. O'Neal, et al. · Clinical Cancer Research

Works count: 5

Citation count:

H-index:

I10-index: